Vontee is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Vonjil. The primary component is Silicon Dioxide; Sodium Pyrophosphate; Pyridoxine Hydrochloride; Sodium Fluoride.
| Product ID | 80687-010_27b32b01-48cf-4892-8843-99689d5b4793 |
| NDC | 80687-010 |
| Product Type | Human Otc Drug |
| Proprietary Name | Vontee |
| Generic Name | Silicon Dioxide, Tetrasodium Pyrophosphate, Pyridoxine Hydrochloride, Sodium Flouride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | VONJIL |
| Substance Name | SILICON DIOXIDE; SODIUM PYROPHOSPHATE; PYRIDOXINE HYDROCHLORIDE; SODIUM FLUORIDE |
| Active Ingredient Strength | 5 g/100g; g/100g; g/100g; g/100g |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VONTEE 90866101 not registered Live/Pending |
PARK, SANGYONG 2021-08-04 |